A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Study To Assess The Safety, Tolerability, and Efficacy Of Oral Ketamine in Patients with Rett Syndrome

Grant

Date/time Interval

  • July 16, 2019 - January 15, 2021
  • Total Award Amount

  • 33950.00
  • Direct Costs

  • 33950.00
  • Sponsor Award Id

  • Contributor

  • Percy, Alan   Principal Investigator